Drugs / sodium zirconium cyclic silicate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06242041 | Feb 2022 → Dec 2024 | cardiac rhythm disease, dialysis disequilibrium syndrome, mineral metabolism disease | Peking University First Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sodium zirconium cyclic silicate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06242041 ↗ |